Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › TGF-beta oligonucleotide for use in treatment of ophthalmic diseases

TGF-beta oligonucleotide for use in treatment of ophthalmic diseases

US Patent 11207341 · Granted Dec 28, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-GDF15 antibody and a dosage regimen for the treatment of cancer2025
Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leu2021
Modified TGF-beta oligonucleotides2020
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2018
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2018
Modified TGF-beta oligonucleotides2018
Modified TGF-beta2 oligonucleotides2017
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2017
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2017
Anti-proliferative combination therapy using certain platinum-based chemotherape2011
Means and methods for the treatment of tumorous diseases2011
Micromonospora species that produces a bafilomycin-like metabolite2010